Rabbit Recombinant Monoclonal delta Sarcoglycan antibody. Suitable for mIHC, IHC-P, IP, WB and reacts with Human samples. Cited in 6 publications.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9% PBS, 0.05% BSA
mIHC | IHC-P | ICC/IF | IP | WB | |
---|---|---|---|---|---|
Human | Tested | Tested | Not recommended | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1.043 µg/mL | Notes Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/100 - 1/250 | Notes Perform heat-mediated antigen retrieval before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/10 - 1/100 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 - 1/10000 | Notes - |
Select an associated product type
Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix.
Delta-sarcoglycan, Delta-SG, 35 kDa dystrophin-associated glycoprotein, 35DAG, SGCD
Rabbit Recombinant Monoclonal delta Sarcoglycan antibody. Suitable for mIHC, IHC-P, IP, WB and reacts with Human samples. Cited in 6 publications.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9% PBS, 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Delta Sarcoglycan also known as SGCD is a protein component of the sarcoglycan complex. It has an approximate mass of 35 kDa. Delta Sarcoglycan localizes predominantly in skeletal and cardiac muscle tissues. This protein forms part of a set of transmembrane glycoproteins which are integral to the muscle cell membrane. It plays an important role in maintaining the structural integrity of muscle cells by linking the sarcolemma to the extracellular matrix.
Delta Sarcoglycan associates with other sarcoglycan proteins to form the sarcoglycan complex. This complex is an essential part of the dystrophin-associated glycoprotein complex (DAGC) which connects the cytoskeleton of a muscle fiber to the extracellular matrix. The proper function of this complex is essential for muscle stability during contraction and relaxation preventing damage to the muscle fibers. It interacts with dystrophin an essential adapter protein which anchors the sarcolemma to the cytoskeleton.
Delta Sarcoglycan plays an integral role in maintaining the integrity of the dystrophin-glycoprotein complex pathway which is vital for muscle function. It also involves the adhesion and signaling pathways that influence muscle cell adhesion and communication. It shows a relationship with dystrophin where mutations in genes coding for any component including delta Sarcoglycan disrupt these pathways and affect muscle tissue integrity.
Delta Sarcoglycan mutations are primarily linked to limb-girdle muscular dystrophy type 2F (LGMD2F) and specific types of cardiomyopathy. These conditions manifest through progressive muscle weakness and deterioration emphasizing the protein’s significance in muscle health. Mutations in the dystrophin protein can exacerbate these diseases further illustrating the important synergy between dystrophin and sarcoglycan complex including delta Sarcoglycan in maintaining muscle integrity.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Purified ab137101 at 1/20 dilution (1μg) immunoprecipitating delta Sarcoglycan in Human skeletal muscle lysate.
Lane 1 (input): Human skeletal muscle lysate 10μg
Lane 2 (+): ab137101 + Human skeletal muscle lysate.
Lane 3 (-): Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab137101 in Human skeletal muscle lysate.
VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration: 5% NFDM/TBST.
Diluting buffer and concentration: 5% NFDM/TBST.
Observed band size: 35 kDa
All lanes: Immunoprecipitation - Anti-delta Sarcoglycan antibody [EPR8706] (ab137101)
Predicted band size: 32 kDa
Immunohistochemical analysis of paraffin-embedded Human heart tissue labelling delta Sarcoglycan with ab137101 at 1/100 dilution.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
All lanes: Western blot - Anti-delta Sarcoglycan antibody [EPR8706] (ab137101) at 1/1000 dilution
Lane 1: Human fetal heart lysate at 10 µg
Lane 2: Human skeletal muscle lysate at 10 µg
All lanes: Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 32 kDa
Observed band size: 35 kDa
Fluorescence multiplex immunohistochemical analysis of the human cardiac muscle (Formalin/PFA-fixed paraffin-embedded sections).
Panel A: merged staining of anti-delta Sarcoglycan (ab137101, red; Opal™690), anti-Titin (Anti-Titin antibody [EPR26167-75] ab307446, green; Opal™520) and anti-Natriuretic peptides A (Anti-Natriuretic peptides A antibody [EPR20247] ab209232, magenta; Opal™570) on human cardiac muscle. Panel B: anti-Titin displayed nucleus and cytoplasm expression. Panel C: anti-Natriuretic peptides A displayed granular cytoplasmic expression. Panel D: anti-delta Sarcoglycan displayed membrane expression. Opal Polymer HRP Ms + Rb was used as a secondary antibody.
The section was incubated in three rounds of staining: in the order of ab137101 at 1/1000 (1.043 μg/ml) dilution, Anti-Titin antibody [EPR26167-75] ab307446 at 1/500 (0.95 μg/ml) dilution, and Anti-Natriuretic peptides A antibody [EPR20247] ab209232 at 1/3000 (0.241 μg/ml) dilution for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. DAPI (blue) was used as a nuclear counter stain.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
Fluorescence multiplex immunohistochemical analysis of the human skeletal muscle (Formalin/PFA-fixed paraffin-embedded sections).
Panel A: merged staining of anti-delta Sarcoglycan (ab137101, green; Opal™690), anti-Fast Myosin Skeletal Heavy chain + MYH4 (Anti-Fast Myosin Skeletal Heavy chain + MYH4 antibody [EPR22880-64] ab221149, magenta; Opal™520) and anti-Slow Skeletal Myosin Heavy chain (Anti-Slow Skeletal Myosin Heavy chain antibody [EPR22697-17] ab234431, red; Opal™570) on human skeletal muscle. Panel B: anti-Fast Myosin Skeletal Heavy chain + MYH4 stained on fast type fibers. Panel C: anti-Slow Skeletal Myosin Heavy chain stained on slow type fibers. Panel D: anti-delta Sarcoglycan stained on membrane of skeletal muscle. Opal Polymer HRP Ms + Rb was used as a secondary antibody.
The section was incubated in three rounds of staining: in the order of ab137101 at 1/1000 (1.043 μg/ml), Anti-Fast Myosin Skeletal Heavy chain + MYH4 antibody [EPR22880-64] ab221149 at 1/1000 (0.505 μg/ml, and Anti-Slow Skeletal Myosin Heavy chain antibody [EPR22697-17] ab234431 at 1/4000 (0.255 μg/ml) for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. DAPI (blue) was used as a nuclear counter stain.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
Fluorescence multiplex immunohistochemical analysis of the human skeletal muscle (Formalin/PFA-fixed paraffin-embedded sections).
Panel A: merged staining of anti-delta Sarcoglycan (ab137101, red; Opal™690), anti-MYH2 (Anti-MYH2 antibody [A4.74] ab264036, cyan; Opal™520) and anti-MYH6 + Slow Skeletal Myosin Heavy chain (Anti-MYH6 + Slow Skeletal Myosin Heavy chain antibody [EPR10891(2)] - BSA and Azide free ab250868, gray; Opal™570) on human skeletal muscle. Panel B: anti-MYH2 stained on the fast twitch type 2A fibers. Panel C: anti-MYH6 + Slow Skeletal Myosin Heavy chain stained on skeletal muscle fiber subtypes. Panel D: anti-delta Sarcoglycan stained on membrane of skeletal muscle. Opal Polymer HRP Ms + Rb was used as a secondary antibody.
The section was incubated in three rounds of staining: in the order of ab137101 at 1/1000 dilution (1.043 μg/ml), Anti-MYH2 antibody [A4.74] ab264036 at 1/1000 dilution (1.116 μg/ml) and Anti-MYH6 + Slow Skeletal Myosin Heavy chain antibody [EPR10891(2)] - BSA and Azide free ab250868 1/5000 dilution (0.209 μg/ml) for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. DAPI (blue) was used as a nuclear counter stain.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com